Suzie Gennaro Rn, Bsn Email & Phone Number

• Promote a portfolio of ultra-rare coagulation disease therapies including Coagadex (Huma Coagulation FactorX), Koate (Human Antihemophilic Factor VIII), and Ryplazim (Human Plasminogen).• Call on Hemophilia Centers, Hematologists/Oncologists, Ophthalmologists (cornea and external eye specialists), Pediatricians, Pharmacists, and Social workersin across the Northeast region.• Collaborate with all internal and external partners cross collaboration with international partners across the globe.• Educate providers on early identification and treatment for Hereditary Factor X Deficiency (HFXD), Plasminogen Deficiency -Type 1(PLGD-1), and Hemophilia A.• Provide education and resources to providers on disease symptoms and diagnosis criteria.• Work closely with Specialty Pharmacies and Distributors to ensure patient access to medications.• Support numerous Bleeding Disorder Foundations and Ophthalmology Societies.• Prepare for a successful launch of Ryplazim (human plasminogen for hypoplasminogenemia) scheduled for 2024.

Boston, Massachusetts, United States

• Promoted Setmelanotide (Imcivree) SQ injection for a rare genetic disease Bardet-Biedl Syndrome (BBS).• Called on Endocrinologists (adult and pediatric), Bariatric Surgeons, Pediatric Nephrologists, retinal specialists, Pediatricians in Obesity Clinics, and major academic centers across the PA, NJ, and DE region.• Collaborated with Commercial, Marketing , Market Access and other departments in a start up environment.• Educated providers on BBS and identify affected patients to initiate therapy for this complicated disease.• Provided education and resources to providers on symptoms and diagnosis criteria.• Key Accomplishment: Prepared for and implemented a successful product launch in June 2022.

United States

• Selected to serve on the Akcea Executive Leadership Team for launch planning as the salesforce representative.• Ranked number one in nation for Ambry Genetic Test Kits submitted and number three in nation for new Health Care Providers testing in 2019.• Developed motivational training tools that were used to educate regional salesforce on best sales practices.• Collaborated closely with Patient Advocacy in Philadelphia to organize the first patient program in the country.• Established six new community Amyloid centers through cross-functional support and leveraging team strengths.• Launched and promote a new first in class treatment for an ultra-rare disease hereditary amyloidosis (Tegsedi).• Provided education and resources to providers and patients on symptoms and diagnosis criteria.• Established relationships and partner with Key Opinion Leaders and work closely with patient advocacy groups.• Planned and implemented patient programs, speaker programs for clinicians, and exhibit at national conferences.• Focused on market development for an ultra-rare disease Familial Chylomicronemia Syndrome (FCS) calling on Endocrinologists, GI, Lipid specialists, and RDs in PA, DE, and south NJ from November 2017 – October 2018.• Key Accomplishment: Identified 27 FCS patients and encouraged physicians to enroll 12 patients for services.

Philadelphia, Pennsylvania

• Promoted Esbriet for Interstitial Pulmonary Fibrosis (IPF) in the Philadelphia North Territory.• Called on an Interstitial Lung Disease (ILD) center in Philadelphia along with other community pulmonary practices.• Educated providers on the disease state, identification of patients, and importance of early treatment.• Collaborated with Pulmonologists, Radiologists, and Specialty Pharmacies. • Worked closely with Clinical Coordinators to educate non-prescribers in the offices with a total office call.• Key Accomplishment: Grew market share of Esbriet increasing from 86.6% to 99.9% to plan.* Recruited by previous manager to Akcea Therapeutics which was a start-up company.

Greater Philadelphia Area

• Promoted Uptravi (oral prostacyclin), Ventavis (inhaled prostacyclin device), Veletri (IV prostacyclin), Opsumit (ERA-enothelin receptor antagonist) and Tracleer (ERA) for treatment of the rare disease state Pulmonary Arterial Hypertension (PAH) throughout the Philadelphia region.• Called on Cardiologists, Pulmonologists, Rheumatologists at community and tertiary hospitals, Cardiac Catheterization Labs, and PAH and Scleroderma Centers.• Focused efforts on hospitals including Lancaster General, Reading Hospital, Thomas Jefferson Hospital, Hahnemann University Hospital, Albert Einstein Medical Center, Abington Memorial Hospital, and Chester County Hospital.• Buillt relationships with providers to establish treatment strategies for PAH and connect them with centers.• Worked with Specialty Pharmacies to get patients on drug, gain market intelligence, and address managed care issues.• Met with hospital Pharmacists and P&T committees to successfully gain formulary access for products. • Cultivated speakers from PAH and Scleroderma Centers to educate community Pulmonologists, Cardiologists, and Rheumatologists on the utilization of products in the management of PAH.• Collaborated with internal Key Account Managers and Medical Science Liaisons as well as Key Opinion Leaders to build referral networks for PAH and Scleroderma Centers.• Certified with the American College of Clinical Pharmacy (ACCP) and the Chest Professional Representative Education Program (PREP).• Achieved 99.5% to goal for Opsumit and 256% to goal for Uptravi in 2016.• Achieved 100% to goal Opsumit doubling sales in the territory and achieving top 10% nationally and 98% to goal for Ventavis in 2015.• Achieved 117% to goal for Opsumit and 98% to goal for Ventavis in 2014.• Won Opsumit National Contest every quarter for three years straight (2010-2012). • Received the Shining Star Award in 2010, 2012, 2015, and 2016.• Received the MVP Award for Northeast Region in 2012.

Greater Philadelphia Area

• Promoted Integrilin (Acute Coronary Syndrome) in the institutional setting throughout a highly competitive territory in the Philadelphia and Delaware regions.• Called on Interventional Cardiologists, Emergency Medicine Physicians, Hospitalists, Intensivists, Pharmacists, and Quality Assurance professionals in hospitals, Cardiac Catheterization Labs, Emergency Departments, Critical Care, and Cardiac Care Units.• Achieved formulary wins through work with P&T Committees at Christiana Hospital, University of Pennsylvania Health System, Temple Hospital, Hahnemann University Hospital, and Abington Memorial Hospital.• Employed relationship based and consultative sales approach understanding client’s needs and practice operations.• Planned and executed the territory businesses plan with focus on pull through of brand messaging and enhanced customer relationships. • Cultivated relationships with Key Opinion Leaders and speakers within the territories. • Developed the National Crusade Registry in conjunction with Duke University to attract and retain ACS patients from door to discharge ensuring that Integrilin was part of the American College of Cardiology and American Hospital Association national guidelines. • Worked closely with hospital administrators in 7 hospitals throughout Philadelphia to teach them how to collect data for the National Crusade Registry and how to analyze the results of the research.• Ranked 23/200 nationally in sales growth and 1/10 in district in 2006 increasing sales by 22.3%.

Greater Philadelphia Area

• Promoted Integrilin in institutional settings throughout the Philadelphia region.• Called on Interventional Cardiologists, Emergency Medicine Physicians, Hospitalists, Intensivists, Pharmacists, and Quality Assurance professionals in hospitals, Cardiac Catheterization Labs, Emergency Departments, Critical Care and Cardiac Care Units.• Participated on the Sales and Marketing Advisory Team to assist in developing new marketing sales aids working closely with Key Opinion Leaders and Interventional Cardiologists to obtain their feedback. • Grew sales by 55% in 2001 and by 100% in 2002.• Ranked 10/200 nationally exceeding sales goals by 23% in 2004.• Received the Millennium Cup Award (aka President’s Club) in 2004.

• Provided nurse to nurse in-service presentations on Integrilin and Remicade use in infusion centers.• Designed and delivered educational programs to train nurses on pharmaceutical products • Trained nurses and infusion center office staff on product billing and reimbursement related issues.

• Promoted Integrilin in major teaching institutions throughout the Philadelphia region.• Called on Interventional Cardiologists, Emergency Medicine Physicians, Hospitalists, Intensivists, Pharmacists, and quality assurance professionals in hospitals, cath labs, Emergency Departments, and Critical Care units.• Collaborated with Cor Therapeutics sales force to co-promote products and achieve or succeed sales goals.

• Administered per diem oncology unit nursing and medication for patients• Coordinated and supervised all nursing and administrative personnel• Designed and educated staff during in-service programs on the latest equipment, new drugs, wound care protocol, and current medical and scientific information that was critical to staff development• Served on hospital’s Policy and Procedure Management Council committees working closely with cross functional teams at the hospital to streamline processes, update protocols, re-engineer processes where necessary in order to improve patient experience within the confines of the hospital’s missionPart-Time Registered Nurse • Provided med-surgical in home care and hospice nursing, interacted with physicians and families, delivered patient education to oncology patients